Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-01-13FDA Approved: ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Alfuzosin Hydrochloride Extended Release by Cipla USA Inc., approving changes to the markete…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: A Clinical Trial Comparing Laser TURP With and Without Dutasteride. [Phase 3]
A Phase 3 trial comparing laser TURP with and without dutasteride for benign prostatic hyperplasia was terminated, and results were posted i…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia [Phase 4]
Phase 4 trial evaluating dutasteride with a flexible dose of tamsulosin on an as-needed basis for benign prostatic hyperplasia; results post…
-
FDA label_change · 2014-12-15FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Finasteride by Accord Healthcare, Inc., updating the drug's labeling. The supplement likely incl…
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Dr Reddys Laboratories Inc)
FDA approved a supplemental application for finasteride by Dr Reddys Laboratories Inc, enabling the generic product to be marketed under AND…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for finasteride from Aurobindo Pharma Limited.
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for finasteride from Aurobindo Pharma Limited under an Abbreviated New Drug Application.
-
FDA approval · 2014-12-14FDA Approved: FINASTERIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for finasteride from Accord Healthcare, Inc., granting an approval to modify the product via a suppl…
-
CLINICAL_TRIALS research · 2014-11-04Clinical Trial Update: Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients [Phase 4]
A Phase 4 clinical trial compares prostatic artery embolization to 532 nm green light photoselective vaporization of the prostate (PVP) for …
-
FDA approval · 2014-11-03FDA Approved: FINASTERIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for finasteride by Sun Pharmaceutical Industries, Inc. (ANDA090508). This action grants approval for…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia [Phase 2]
A Phase 2 clinical trial evaluates the efficacy of vardenafil in symptomatic benign prostatic hyperplasia. The study has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) [Phase 3]
Phase 3 trial of JALYN for benign prostatic hyperplasia and Chronic prostatitis/chronic pelvic pain syndrome was terminated.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. [Phase 4]
A Phase 4 study evaluating tamsulosin OCAS for nighttime voiding in men with benign prostatic hyperplasia has completed.
-
FDA approval · 2014-09-26FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for finasteride submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-09-22FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for doxazosin mesylate from Aurobindo Pharma Limited under the DOXAZOSIN ANDA, signaling regulatory …
-
FDA approval · 2014-09-21FDA Approved: DOXAZOSIN — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for doxazosin from Apotex Corp., indicating updated labeling/manufacturing aspects for the gener…
-
FDA approval · 2014-09-21FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Finasteride submitted by Dr. Reddy's Laboratories Limited. This action refers to a supplemental …
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 4]
A Phase 4 clinical trial comparing FLOMAX (tamsulosin) and HYTRIN (terazosin) in men with benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia
A completed clinical trial evaluating the safety profile of Secotex in patients with benign prostatic hyperplasia. The update summarizes saf…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) [Phase 2]
A Phase 2 trial comparing FLOMAX (tamsulosin) to placebo in men with acute urinary retention related to benign prostatic hyperplasia has com…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
A completed clinical trial update evaluating prescription event monitoring in patients with benign prostatic hyperplasia.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
The trial update reports on the impact of Alna Ocas on nocturia in patients with LUTS suggestive of benign prostatic hyperplasia; the study …
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients [Phase 4]
Phase 4 clinical trial evaluating the therapeutic action of tamsulosin and finasteride in symptomatic benign prostatic hyperplasia has compl…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia
A clinical trial evaluated ALNA (tamsulosin) for the primary symptoms of benign prostatic hyperplasia; the study status is completed.
-
CLINICAL_TRIALS research · 2014-09-19Clinical Trial Update: Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
An observational study evaluating functional benign prostatic hyperplasia symptoms in patients who switched from phytotherapy to ALNA (tamsu…